Advocating for collaboration among key partners to promote diversity in clinical studies amid policy challenges in the United States of America

Advocating for collaboration among key partners to promote diversity in clinical studies amid policy challenges in the United States of America

Abstract The lack of diversity in clinical studies has significant ethical and health consequences, limiting the development of effective treatments for diverse populations. Homogeneous participation in clinical studies contributes to health disparities, particularly among historically underrepresen...

Full description

Saved in:
Bibliographic Details
Main Authors: Samuel Byiringiro, Juliana K. Garcia, Nsenga Farrell, Bunmi Ogungbe, Rifath Ara Alam Barsha, Hailey N. Miller, Evans Whitaker, Paul Wang, William E. Rosa, Barbara E. Bierer, Cheryl R. Himmelfarb, Erin D. Michos, Koen De Lombaert, Maya Berdichesky, Stephan Busque, Latha Palaniappan, Eldrin Lewis, Fatima Rodriguez, Hannah Valantine
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Trials
Subjects:
Clinical research
Clinical trials
Clinical studies
Regulatory institutions
Diversity in clinical research
Online Access:https://doi.org/10.1186/s13063-025-08820-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13063-025-08820-y

Similar Items